###begin article-title 0
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
Functional COMT Val158Met Polymorphism, Risk of Acute Coronary Events and Serum Homocysteine: The Kuopio Ischaemic Heart Disease Risk Factor Study
###end article-title 0
###begin p 1
Conceived and designed the experiments: GK SV TT JM PH JK JS. Performed the experiments: SV JM JV GA IE EI. Analyzed the data: SV TT MK JM PH KN MM JS. Contributed reagents/materials/analysis tools: GA IE JT JS EI. Wrote the paper: GK SV TT MK JM JV PH GA IE KN MM JK JT JS EI.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 462 463 462 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 483 488 483 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT)</italic>
The role of circulating levels of total homocysteine tHcy in the development of coronary heart disease (CHD) is still under debate. One reason for conflicting results between previous studies on homocysteine and heart diseases could be consequence of different interactions between homocysteine and genes in different study populations. Many genetic factors play a role in folate-homocysteine metabolism, like functional polymorphism (Val108Met) in the Catechol-O-methyltransferase (COMT) gene.
###end p 3
###begin title 4
Methodology and Findings
###end title 4
###begin p 5
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 503 508 503 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> COMT</italic>
###xml 1058 1062 1058 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 197 200 <span type="species:ncbi:9606">men</span>
###xml 268 271 <span type="species:ncbi:9606">men</span>
###xml 448 451 <span type="species:ncbi:9606">men</span>
###xml 1183 1186 <span type="species:ncbi:9606">men</span>
Our aim was to examine the role of COMT Val158Met polymorphism and interaction of this polymorphism with serum tHcy and folate concentration on the risk of acute coronary and events in middle-aged men from eastern Finland. A population-based prospective cohort of 792 men aged 46-64 years was examined as part of the Kuopio Ischaemic Heart Disease Risk Factor Study. During an average follow-up of 9.3 years, there were 69 acute coronary events in men with no previous history of CHD. When comparing the COMT low activity genotype with the others, we found an age and examination year adjusted hazard rate ratio (HRR) of 1.73 (95% confidence interval (CI), 1.07-2.79), and an age, examination year, serum LDL and HDL cholesterol, and triglyceride concentration, systolic blood pressure and smoking adjusted HRR of 1.77 (95% CI, 1.05-2.77). Although serum tHcy concentration was not statistically significantly associated with acute coronary events (HRR for the highest third versus others 1.52, 95% CI, 0.93-2.49), subjects with both high serum tHcy and the COMT low activity genotype had an additionally increased adjusted risk of HRR 2.94 (95% CI 1.50-5.76) as compared with other men.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
This prospective cohort study suggests that the functional COMT Val158Met polymorphism is associated with increased risk of acute coronary events and it may interact with high serum tHcy levels.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
Nutrition has a significant role in the prevention of many chronic diseases such as cardiovascular disease (CVD), cancers and degenerative brain diseases. Major risk and protective factors in the diet are now known, however, new candidates in both categories are still being revealed. Especially, the associations between nutrition and genes in disease risk have not been studied extensively.
###end p 9
###begin p 10
###xml 135 138 135 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-HomocysteineStudies1">[1]</xref>
###xml 140 143 140 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Nygard1">[2]</xref>
###xml 355 358 355 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Voutilainen1">[3]</xref>
###xml 359 362 359 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Voutilainen3">[5]</xref>
###xml 464 467 464 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Voutilainen3">[5]</xref>
###xml 468 471 468 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Voutilainen4">[6]</xref>
During the last years, elevated plasma/serum total homocysteine (tHcy) has been one of the most intensely studied risk factors for CVD [1], [2]. We have shown in the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study that a high serum concentration and dietary intake of folate are associated with a significantly lower risk of acute coronary events [3]-[5], while an elevated plasma tHcy concentration was not significantly associated with an increased risk [5]-[6].
###end p 10
###begin p 11
###xml 174 177 173 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Lievers1">[7]</xref>
###xml 179 182 178 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Klerk1">[8]</xref>
###xml 310 311 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 369 370 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 605 609 604 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 685 688 684 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Zhu1">[9]</xref>
###xml 690 694 689 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Zhu2">[10]</xref>
###xml 777 781 776 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Tiihonen1">[11]</xref>
###xml 863 867 862 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-LachmanHM1">[12]</xref>
There are some well-known genetic factors that have a role in the folate-Hcy metabolism, like methylenetetrahydrofolate reductase (MTHFR) and cystathionine ss-synthase (CBS) [7], [8]. There are also some less studied genetic factors in that metabolism, which could have a role in Hcy-CVD association. Catechol-O-methyltransferase (COMT) is an enzyme that catalyzes the O-methylation of various compounds, like catechol estrogens and dietary polyphenols, using S-adenosylmethionine (SAM) as the methyl donor and has also a role in dopamine inactivation. A common functional polymorphism (Val108Met) in the COMT gene is associated with a three- to four-fold variation in enzyme activity [9], [10]. The low activity genotype (Met158Met) has been associated with heavy alcohol use [11] and some other psychiatric disorders, such as bipolar disorder and schizophrenia [12].
###end p 11
###begin p 12
###xml 256 260 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Zhu2">[10]</xref>
###xml 351 355 351 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
A unifying hypothesis that hyperhomocysteinemia may exert its pathogenic effects largely through metabolic accumulation of SAH, a potent non-competitive inhibitor of COMT-mediated methylation metabolism of various catechol substrates was recently proposed [10]. Therefore we wanted to test the hypothesis that the functional polymorphism Val108Met in COMT gene could modify the coronary event risk, and that the effect is further strengthened by elevated tHcy.
###end p 12
###begin title 13
Materials and Methods
###end title 13
###begin title 14
Study design and population
###end title 14
###begin p 15
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Salonen1">[13]</xref>
###xml 829 833 829 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 214 217 <span type="species:ncbi:9606">men</span>
###xml 346 358 <span type="species:ncbi:9606">participants</span>
###xml 594 597 <span type="species:ncbi:9606">men</span>
###xml 776 779 <span type="species:ncbi:9606">men</span>
###xml 867 870 <span type="species:ncbi:9606">men</span>
###xml 963 966 <span type="species:ncbi:9606">men</span>
###xml 1052 1064 <span type="species:ncbi:9606">participants</span>
The Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study is an ongoing prospective population-based cohort study designed to investigate risk factors for CVD, atherosclerosis and related outcomes in middle-aged men from eastern Finland [13], a population with one of the highest recorded rates of coronary heart disease (CHD). A total of 2682 participants (82.9% of those eligible), aged 42, 48, 54, or 60 years, were enrolled in the study between 1984 and 1989. The baseline examinations for the present prospective cohort study were carried out during 1991 to 1993. Out of a total of 1229 men eligible for the study, 52 had died, or suffered severe illness, or had migrated from the region, and 139 could not be contacted or refused to participate. Of the remaining 1038 men, data on serum folate and tHcy concentration and COMT genotype were available for 1012 men. As previous disease may affect circulating levels of tHcy and dietary intake of nutrients, men with prevalent CHD (n = 220) were excluded from the main analyses of this study. All participants signed a written informed consent. The Research Ethics Committee of the University of Kuopio has approved the KIHD study protocol.
###end p 15
###begin title 16
Measurements
###end title 16
###begin p 17
The subjects came to give venous blood samples between 8 and 10 in the morning. They were instructed to abstain from ingesting alcohol for three days and from smoking and eating for 12 hours. After the subject had rested in the supine position for 30 minutes, venous blood samples were collected into vacuum tubes (Venoject; Terumo, Leuven, Belgium). No tourniquet was used. Blood for folate and cholesterol determination and for lipoprotein separation was drawn into serum tubes.
###end p 17
###begin p 18
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-HallikainenT1">[14]</xref>
###xml 440 444 440 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
COMT polymorphism is generated by the presence of guanine or adenine at nucleotide 475 encoding a valine (Val) or methionine (Met) at codon 158 [14]. The polymorphism results in three different genotypes: homozygous for the low activity allele (Met/Met), homozygous for the high activity allele (Val/Val), and heterozygous (Met/Val). DNA was extracted from 10 ml of venous EDTA blood using standard salting-out or phenol-chloroform assays. COMT genotypes were determined by restriction fragment length polymorphism (RFLP) analysis from the DNA by an investigator unaware of the phenotype. A 179 base-pair polymerase chain reaction product was generated using the forward 5'-CTG CTG GAG CTG GGG GCC GAC-3' and reverse 5'-AGG TCT TCA GGA ATG C-3' primers. The polymerase chain reaction product was treated with HSP 92 II restriction endonuclease. The diagnostic bands were 179 (Val) and 139 (Met).
###end p 18
###begin p 19
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Schwab1">[15]</xref>
The serum tHcy concentration was analyzed by HPLC in 2001 at the National Public Health Institute, Helsinki, Finland [15]. The coefficients of variation (CV) between batches (n = 30) for two pooled serum samples were 4.3% and 5.4%.
###end p 19
###begin p 20
###xml 26 28 26 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
Serum folate and vitamin B12 concentrations were measured by radioimmunoassay (Quantaphase II, Bio-Rad, Hercules, California, USA). These measurements were carried out in 1998 from serum samples collected during 1991-3 and kept frozen at -80degreesC. The between-batch CV of quality control serums (Lyphochek Immunoassay Plus Control levels 1, 2, 3, Bio Rad Laboratories, ECS Division, Anaheim, California, USA) for folate levels of 5.5, 13.4 and 23.6 nmol/L were 6.4, 6.7 and 6.7%, respectively (n = 16).
###end p 20
###begin p 21
###xml 109 113 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Salonen2">[16]</xref>
Serum lipoproteins were separated from fresh serum samples by combined ultracentrifugation and precipitation [16]. Serum total, LDL and HDL cholesterol (Kone Instruments, Espoo, Finland) and triglyceride (Boehringer Mannheim, Mannheim, Germany) concentrations were determined enzymatically with an autoanalyzer (Kone Specific, Kone Instruments, Finland).
###end p 21
###begin p 22
###xml 571 575 571 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Salonen3">[17]</xref>
Two trained nurses measured resting blood pressure with a random-zero mercury sphygmomanometer (Hawksley, United Kingdom). The measuring protocol included, after supine rest of five minutes, three measurements in the supine, one in the standing and two in the sitting position at five minute intervals. The mean of all six measurements was used as the systolic and diastolic blood pressure. Body mass index (BMI) was computed as the ratio of weight to the square of height. Assessment of smoking and ischemic disease in the family was carried out as described previously [17].
###end p 22
###begin title 23
Ascertainment of follow-up events
###end title 23
###begin p 24
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Tuomilehto1">[18]</xref>
###xml 342 346 342 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Tuomilehto1">[18]</xref>
###xml 641 645 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Tuomilehto1">[18]</xref>
###xml 1006 1009 <span type="species:ncbi:9606">men</span>
The province of Kuopio participated in the multinational MONICA (MONItoring of Trends and Determinants of Cardiovascular Disease) project [18], in which detailed diagnostic information of all heart attacks that occurred by December 1992 was collected prospectively. Diagnostic classification was made by the FINMONICA coronary registry group [18]. Data on acute coronary events between January 1993 and December 2002 were obtained by computer linkage to the national hospital discharge register and classified using identical diagnostic criteria, based on symptoms, cardiac enzymes and electrocardiographic findings as documented previously [18]. The average follow-up time was 9.3 years. If multiple non-fatal events occurred during the follow-up, the first event for each subject was considered as end point for the analyses. According to the diagnostic classification of the events there were 43 definite and 17 possible acute myocardial infarctions (AMI) and 9 typical prolonged chest pain episodes in men free of prior CHD at study baseline, a total of 69 events without history.
###end p 24
###begin title 25
Statistics
###end title 25
###begin p 26
###xml 352 356 350 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
The data are expressed as means+/-SD. Means were compared by analysis of variance (ANOVA). The subjects were classified into thirds according to their serum folate and tHcy concentration and those in the highest third were compared with those in the two lower thirds. The relationship of serum folate and tHcy with the risk of acute coronary events in COMT genotypes was analyzed using the Cox proportional hazards models. We used age, examination year, serum HDL and LDL cholesterol and triglycerides, mean systolic blood pressure and smoking as covariates in the main analysis.
###end p 26
###begin p 27
###xml 320 324 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 638 642 629 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Hosmer1">[19]</xref>
###xml 663 665 654 656 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 669 671 660 662 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 675 677 666 668 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">01</sub>
###xml 690 692 681 683 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 798 801 789 792 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10 </sub>
###xml 808 810 799 801 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">01</sub>
###xml 1124 1129 1113 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> COMT</italic>
Interactions between genotype and serum tHcy and genotype and folate on the risk of acute coronary events were tested on both the multiplicative and additive scales. First, the ]multiplicative interaction between genotype and serum tHcy was assessed by the use of a product term that was serum tHcy >/=11.3 micromol/L * COMT low activity (Met158Met) genotype. Where the estimated beta coefficient for the product term does not equal zero or the respective hazard rate ratio (HRR) does not equal one, a multiplicative interaction exists. An additive interaction was assessed using the estimated relative excess risk for interaction (RERI) [19]. Briefly, RERI = HRR11-HRR10-HRR01+1, where HRR11 refers to the hazard rate ratio of acute coronary event associated with both genotype and serum tHcy, HRR10 and HRR01 are hazard rate ratios of acute coronary event associated with genotype or serum tHcy. The estimated RERI value that does not equal zero suggests an additive interaction. The interactions between genotype and folate were assessed in the same way. The product term for serum folate was serum folate </=8.3 nmol/L * COMT Met158Met genotype.
###end p 27
###begin p 28
The confidence intervals (CI) were estimated on the basis of the assumption of asymptotic normality of the estimates. All tests of significance were two-sided. P-values <0.05 were considered significant. Data were analyzed using SPSS 11.0 for Windows (SPSS Inc., Chicago, IL, USA).
###end p 28
###begin title 29
Results
###end title 29
###begin title 30
Characteristics
###end title 30
###begin p 31
###xml 472 479 472 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000181-t001">Table 1</xref>
###xml 57 60 <span type="species:ncbi:9606">men</span>
###xml 127 130 <span type="species:ncbi:9606">men</span>
At the beginning of follow-up, the mean age of the study men was 55.4 years. During an average follow-up time of 9.3 years, 69 men with no previous CHD at baseline suffered an acute coronary event. Those subjects who suffered an acute coronary event had higher systolic blood pressure, serum total and LDL cholesterol and triglycerides and a higher prevalence of ischemic heart disease in the family, and also had lower serum folate concentration than the other subjects (Table 1).
###end p 31
###begin p 32
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 211 212 211 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 305 309 305 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 353 360 353 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000181-t002">Table 2</xref>
###xml 434 438 434 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 585 589 585 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 664 669 664 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> COMT</italic>
The distribution of the COMT genotypes was consistent with the Hardy-Weinberg equilibrium. The frequency of the Val/Val, Val/Met and Met/Met genotypes in healthy controls was 22.0, 50.3 and 27.7%, respectively (p = 0.78). In the whole study population the prevalence of heterozygosity and homozygosity of COMT Met158 were 49.4% and 28.9%, respectively. Table 2 exhibits baseline characteristics of the study subjects according to the COMT genotypes. There was no significant difference in by age, serum HDL, LDL or triglycerides, systolic blood pressure or smoking status in different COMT genotypes. There was also no statistically significant association between COMT genotypes with either serum tHcy or folate levels.
###end p 32
###begin title 33
Serum homocysteine and folate and the risk of acute coronary event
###end title 33
###begin p 34
###xml 209 210 203 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 329 330 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 618 619 612 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 97 100 <span type="species:ncbi:9606">Men</span>
###xml 503 506 <span type="species:ncbi:9606">men</span>
Serum tHcy concentration was not significantly associated with the risk of acute coronary event. Men with high serum tHcy concentrations (highest third, >/=11.3 micromol/L) had a 1.41-fold (95% CI, 0.87-2.29, p = 0.164) risk of acute coronary events after adjusting for age and examination year and 1.52-fold (95% CI, 0.93-2.49, p = 0.092) risk after adjusting for age, examination year, serum HDL and LDL cholesterol and triglyceride concentration, systolic blood pressure and smoking as compared with men with lower serum tHcy. Additional adjustment with serum folate decreased this risk to 1.32 (95% CI, 0.80-2.18, p = 0.283). Subdividing serum tHcy into quarters or adjustment for other dietary or lifestyle factors did not reveal significant associations between tHcy and coronary events.
###end p 34
###begin p 35
###xml 365 366 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
A low serum folate concentration (lowest third, </=8.3 nmol/L) was associated with a significantly higher risk of acute coronary events. In the Cox model adjusted for age and examination years, and serum LDL- and HDL- cholesterol and triglycerides, systolic blood pressure and smoking, the HRR for those in the lowest serum folate third was 1.72 (95% CI 1.06-2.79, p = 0.028) as compared with others. Adjustment for other nutritional or lifestyle factors did not substantially attenuate this association.
###end p 35
###begin title 36
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
COMT low activity Met158Met genotype and the risk of acute coronary event
###end title 36
###begin p 37
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 129 133 129 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 237 238 237 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 408 409 408 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 116 119 <span type="species:ncbi:9606">men</span>
The COMT low activity genotype was associated with a higher risk of acute coronary events. In the comparison of the men with the COMT Met158Met genotype with the others, we found age and examination year adjusted HRR of 1.73 (1.07-2.79, p = 0.025), and age, examination year, serum HDL and LDL cholesterol, and triglyceride concentration, systolic blood pressure and smoking adjusted HRR of 1.77 (1.05-2.77, p = 0.030).
###end p 37
###begin title 38
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
Interactions between serum homocysteine and folate, COMT Met158Met genotype and acute coronary event risk
###end title 38
###begin p 39
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000181-t003">Table 3</xref>
###xml 222 226 222 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
Table 3 presents the adjusted HRR's and 95% CI's of incident coronary events associated with gene-tHcy and gene-folate interactions. HRR's for coronary events were 1 for individuals with 'non-risk' genotype: subjects with COMT Val/Met genotype and either low serum tHcy (lowest third) for homocysteine-gene analyses or high serum folate (highest third) for folate - gene interaction analyses. HRR for interaction and RERI with 95% CI's are also displayed.
###end p 39
###begin p 40
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 129 133 129 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 265 266 265 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 277 284 277 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000181-t003">Table 3</xref>
###xml 452 453 452 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 569 573 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 588 595 588 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000181-t003">Table 3</xref>
###xml 703 707 703 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 733 734 733 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 750 758 750 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000181-g001">Figure 1</xref>
###xml 868 872 864 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 963 967 953 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 1030 1034 1020 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 1112 1116 1102 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 15 18 <span type="species:ncbi:9606">men</span>
###xml 99 102 <span type="species:ncbi:9606">men</span>
###xml 554 557 <span type="species:ncbi:9606">men</span>
When comparing men with both high plasma tHcy (highest third) and COMT Met158Met genotype with the men with lower serum tHcy and COMT Met158Val or Val158Val genotype, we found age and examination year adjusted HRR of 2.60 of acute coronary event (95% CI 1.35-5.03, p = 0.004) (Table 3). After adjusting for age, examination years, serum HDL and LDL cholesterol and triglycerides, systolic blood pressure and smoking the HRR was 2.94 (95% CI 1.50-5.76, p = 0.002). There was no significant association between high serum tHcy and acute coronary events in men with other COMT genotypes. In Table 3, however, the results suggest no statistically significant multiplicative nor additive interaction between COMT genotype and serum tHcy (p-values >0.05). Figure 1 presents Kaplan-Meier survival curves for 1) study subjects with lower serum tHcy (<11.28 micromol/L) and no COMT Met158Met genotype, 2) study subjects with higher serum tHcy (>/=11.28 micromol/L) and no COMT Met158Met genotype, 3) study subjects with low serum tHcy and COMT Met158Met genotype, and 4) for the study subjects with higher serum tHcy and COMT Met158Met high-risk genotype.
###end p 40
###begin p 41
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 166 170 166 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 236 237 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 305 309 305 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 321 328 321 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000181-t003">Table 3</xref>
###xml 369 373 369 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 482 483 482 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 131 134 <span type="species:ncbi:9606">Men</span>
###xml 266 269 <span type="species:ncbi:9606">men</span>
In order to study the interaction between serum folate levels and COMT genotypes, we conducted similar analyses with serum folate. Men with both low serum folate and COMT Met158Met genotype had a adjusted HRR of 2.80 (95% CI 1.33-3.90, p = 0.007) when compared with men having high serum folate and other COMT genotypes (Table 3). Nevertheless, the interaction between COMT genotype and serum folate was not statistically significant either on the multiplicative or additive scale (p-values >0.05).
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Eriksson1">[20]</xref>
###xml 168 171 <span type="species:ncbi:9606">men</span>
###xml 386 394 <span type="species:ncbi:9606">patients</span>
###xml 509 512 <span type="species:ncbi:9606">men</span>
###xml 732 735 <span type="species:ncbi:9606">men</span>
The main finding of this study is that the common functional Met158Met polymorphism of the COMT gene is an independent risk factor for acute coronary events in Finnish men and it may also interact with serum tHcy to increase the risk of coronary events further. Recently Eriksson and colleagues we have shown opposite results. In their prospectively followed hypertensive cohort of 174 patients and 348 controls the low activity genotype reduces the risk of myocardial infarction [20]. They also noticed that men who were homozygous for the low activity allele of COMT had increased serum levels of estradiol, and concluded that the altered estrogen status could be involved in this effect. In that study 74% of study subjects were men and interaction between COMT genotype and homocysteine were not studied.
###end p 43
###begin p 44
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 245 249 245 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Zhu2">[10]</xref>
###xml 397 401 397 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 1269 1273 1269 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Zhu2">[10]</xref>
###xml 1896 1902 <span type="species:ncbi:9606">people</span>
It is biologically plausible that the COMT variant directly modifies the association between high serum tHcy levels and risk of CHD because of prior evidence suggests that COMT is one of the key enzymes in the methionine-homocysteine metabolism [10]. An alternative explanation for our findings is that other genes on chromosome 22 with functional mutations are in linkage disequilibrium with the COMT variant evaluated herein. Homocysteine is a sulphur-containing amino acid which is converted to SAM, formed only from the dietary essential amino acid methionine. Via the action of SAM adenosyltransferase, methionine is converted to SAM, which is the major biological methyl donor required for numerous cellular processes, including the formation of creatine and methylation of phospholipids. These reactions are catalyzed by various methyltransferases, such as COMT, which demethylates s-adenosylmethionine to SAH, the immediate precursor of homocysteine. Recently a unifying hypothesis that hyperhomocysteinemia may exert its pathogenic effects largely through the metabolic accumulation of SAH, which is a potent non-competitive inhibitor of COMT mediated methylation of various catechol substrates, such as catecholamines and catechol estrogens has been proposed [10]. In the case of endogenous catecholamines in peripheral tissue, inhibition of their methylation by SAH could theoretically result in elevation of blood or tissue levels of catecholamines, and consequently, over-stimulation of the cardiovascular system. The endogenous catecholamines are also potentially reactive molecules. Our findings from the KIHD Study are in line with recent hypothesis; it seems that a moderate increase of serum tHcy (which may cause a moderate inhibition of the COMT activity) may not reduce the level of COMT activity below the minimally-required level in the whole study population. However, in people already with a compromised COMT activity, the pathogenic consequences would be more readily detectable, and risk of acute coronary events could increase.
###end p 44
###begin p 45
###xml 84 88 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Alfthan1">[21]</xref>
###xml 90 94 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Knekt1">[22]</xref>
###xml 354 358 354 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Knekt1">[22]</xref>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000181-Norio1">[23]</xref>
The mean serum tHcy concentrations are rather similar to other studies from Finland [21], [22], a country where severe or moderate hyperhomocysteinemia is relatively uncommon. The negative tHcy-AMI findings in another Finnish study were proposed to be due to the low prevalence of mutations predisposing to hyperhomocysteinemia in the Finnish population [22]. Indeed, homocystinuria is a hereditary disorder which is extremely rare in Finland [23].
###end p 45
###begin p 46
Our study is limited by the small number of outcome events, reducing the power and preventing testing for interaction analyses or including multiple covariates in the models. The major strength of this study is its prospective population-based study design with a long follow-up period.
###end p 46
###begin p 47
###xml 249 253 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 361 365 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 114 117 <span type="species:ncbi:9606">men</span>
In summary, although a high circulating level of tHcy does not appear to predict acute coronary events in healthy men living in eastern Finland, high tHcy could be a modest risk factor in subpopulations with predisposing gene mutations, such as the COMT low activity Met158Met genotype. Additional studies will be required to provide more information about the COMT gene in cardiovascular health.
###end p 47
###begin p 48
###xml 104 108 104 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 32 38 <span type="species:ncbi:9606">people</span>
We thank our staff of almost 30 people for helping with data collection and Dr. Matti Karvonen, MD, for COMT genotyping. The funding sources had no role in the design, data collection, analysis, or interpretation of the study or in the decision to submit this manuscript for publication.
###end p 48
###begin title 49
References
###end title 49
###begin article-title 50
Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.
###end article-title 50
###begin article-title 51
Total homocysteine and cardiovascular disease.
###end article-title 51
###begin article-title 52
Low serum folate levels are associated with an excess risk of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study.
###end article-title 52
###begin article-title 53
Low dietary folate intake is associated with an excess incidence of acute coronary events. The Kuopio Ischaemic Heart Disease Risk Factor Study.
###end article-title 53
###begin article-title 54
Serum folate, plasma homocysteine and incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study.
###end article-title 54
###begin article-title 55
Plasma total homocysteine concentration and the risk of acute coronary events: the Kuopio Ischemic Heart Disease Risk factor Study.
###end article-title 55
###begin article-title 56
Genetics of hyperhomocysteinaemia in cardiovascular disease.
###end article-title 56
###begin article-title 57
MTHFR Studies Collaboration Group. MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.
###end article-title 57
###begin article-title 58
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis.
###end article-title 58
###begin article-title 59
On the mechanism of homocysteine pathophysiology and pathogenesis: a unifying hypothesis.
###end article-title 59
###begin article-title 60
Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism.
###end article-title 60
###begin article-title 61
Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder.
###end article-title 61
###begin article-title 62
Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study.
###end article-title 62
###begin article-title 63
Lack of association between the functional variant of the catechol-o-methyltransferase (COMT) gene and early-onset alcoholism associated with severe antisocial behavior.
###end article-title 63
###begin article-title 64
Betaine supplementation with a low calorie diet decreases plasma homocysteine concentrations but does not affect body weight, body composition, resting energy expenditure or serum lipid concentrations.
###end article-title 64
###begin article-title 65
###xml 128 131 <span type="species:ncbi:9606">men</span>
Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentration: a four year follow-up study in men.
###end article-title 65
###begin article-title 66
###xml 100 103 <span type="species:ncbi:9606">men</span>
High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men.
###end article-title 66
###begin article-title 67
Acute myocardial infarction (AMI) in Finland: baseline data from the FINMONICA AMI register in 1983-1985.
###end article-title 67
###begin article-title 68
Confidence interval esitimation of interaction.
###end article-title 68
###begin article-title 69
###xml 58 59 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
Association between the low activity genotype of catechol-O-methyltransferase and myocardial infarction in a hypertensive population.
###end article-title 69
###begin article-title 70
Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study.
###end article-title 70
###begin article-title 71
Hyperhomocystinemia. A risk factor or a consequence of coronary heart disease?
###end article-title 71
###begin article-title 72
Diseases in Finland and Scandinavia.
###end article-title 72
###begin title 73
Figures and Tables
###end title 73
###begin p 74
###xml 118 122 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 213 217 203 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 282 286 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 356 360 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
Kaplan-Meier survival curves for 1) study subjects with lower serum total homocysteine (tHcy<11.28 micromol/L) and no COMT Met158Met genotype, 2) study subjects with higher serum tHcy (>/=11.28 micromol/L) and no COMT Met158Met genotype, 3) study subjects with lower serum tHcy and COMT Met158Met genotype, and 4) study subjects with higher serum tHcy and COMT Met158Met genotype.
###end p 74
###begin title 75
###xml 46 47 46 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt102">*</xref>
Baseline characteristics of the study subjects*
###end title 75
###begin p 76
Abbreviations: BMI = body mass index; HDL = high density lipoprotein; IHD = ischemic heart disease; LDL = low density lipoprotein; tHcy = total homocysteine concentration.
###end p 76
###begin p 77
Data are expressed as the mean+/-SD unless otherwise indicated.
###end p 77
###begin title 78
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 100 101 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt104">*</xref>
Characteristics of the study subjects according to the catechol-o-methyltransferase (COMT) genotypes*
###end title 78
###begin p 79
Abbreviations: BMI = body mass index; HDL = high density lipoprotein; IHD = ischemic heart disease; LDL = low density lipoprotein; tHcy = total homocysteine concentration.
###end p 79
###begin p 80
Data are expressed as the mean+/-SD unless otherwise indicated.
###end p 80
###begin title 81
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 91 92 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt106">*</xref>
Adjusted HRR and 95% CI of Incident Acute Coronary Events Associated with the COMT Genotype*, Plasma tHcy and Serum Folate and Gene-Homocysteine and Gene-Folate Interactions
###end title 81
###begin p 82
###xml 54 55 54 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 135 136 135 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
Abbreviations: CI, confidence interval; COMT, catehol-O-methyltransferase; fol, serum folate concentration; HRR, hazard rate ratio; HRRi, hazard rate ratio for a multiplicative interaction; RERI, relative excess risk for interaction; tHcy, serum total homocysteine concentration.
###end p 82
###begin p 83
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 214 218 210 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
COMT low activity Met158Met is 'at-risk' genotype for this study. The comparison group for the HRRs in the first three columns of the table is the same, i.e. subjects with lower plasma tHcy (<11.3 micromol/L) with COMT Met158Val or Val158Val genotype.
###end p 83
###begin p 84
Model 1 is adjusted for age and examination years.
###end p 84
###begin p 85
Model 2 is adjusted for age, examination years, serum HDL and LDL cholesterol and triglycerides, systolic blood pressure and smoking
###end p 85
###begin p 86
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 86
###begin p 87
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Supported by Academy of Finland (grants 201688 and 80185 to SV, 200942 to JK), Juho Vainio Foundation and Yrjo Jahnsson Foundation. The KIHD study was supported by grants from the Academy of Finland (grants 41471, 1041086 and 2041022 to JTS) and the National Heart, Lung and Blood Institute of the USA (grant HL44199 to GAK).
###end p 87

